Activity value 81peru Buyer&Supplier,Last transaction date:
2011-11-07Address: peru,lima,av nicolas ayllon no 3130 ate vitar
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for corp infarmasa s.a. from 2010 to 2011.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2011, the company has completed 61 transactions, with a transaction quantity of 28671.89 and a transaction weight of 31034.03.
Product description
CEFAPORIN 250 MG/5ML SUSP. CAJA X 1 FCO 100 ML US
Expand
+View All
Partners
Total 2
RankCompanyTransactionsPerDetail
1global inc.
united statesbuyer,they trade on 2010-12-29
20.03%
>
2genmed s.a.
argentinasupplier,they trade on 2009-05-11
10.02%
>
Products
Total 60
ProductsTransactionsPerDetail
voltaren 14038.67%>
fer-in-sol 14038.67%>
bronax 14038.67%>
moxifloxacin hydrochloride 12434.25%>
serotonin 12434.25%>
+View All
Hscode rank
Total 48
HSCode NameTransactionsPerDetail
HS 300490290014038.67%>
HS 300420190012434.25%>
HS 30041010004311.88%>
HS 4819200000226.08%>
HS 293500900041.1%>
+View All
Trading Area
Total 2
AreaTransactionsPerDetail
united states20.03%>
argentina10.02%>
Port statistics
Total 2
Port NameTransactionsPerDetail
callao10.02%>
cartagena10.02%>
corp infarmasa s.a. is peru Buyer&Supplier,
and primarily engages in the import and export business of products such as voltaren,fer-in-sol,bronax.
According to the 52wmb.com global trade database, as of 2011-11-07, the company has completed 5934 international trades,
with its main trading regions covering united states,argentina etc.
The core products include HS3004902900,HS3004201900,HS3004101000 etc,
often transported via callao,port cartagena etc,
and its main trading partners are global inc.,genmed s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on corp infarmasa s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.